Evidence map›Paper›PMID 41269280›Full record

ArticleBriefings in bioinformatics2025

Evaluation of single-template ligand-based methods for the discovery of small-molecule nucleic acid binders.

Dávid Bajusz, Anita Rácz, Janusz M Bujnicki, Filip Stefaniak

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dávid BajuszMedicinal Chemistry Research Group, Hungarian Research Network Research Centre for Natural Sciences, Magyar tudósok krt. 2, Budapest 1117, Hungary.ORCID 0000-0003-4277-9481
Anita RáczPlasma Chemistry Research Group, Hungarian Research Network Research Centre for Natural Sciences, Magyar tudósok krt. 2 Budapest 1117, Hungary.ORCID 0000-0001-8271-9841
Janusz M BujnickiLaboratory of Bioinformatics and Protein Engineering, International Institute of Molecular and Cell Biology in Warsaw, ul. Ks. Trojdena 4, Warsaw, 02-109, Poland.ORCID 0000-0002-6633-165X
Filip StefaniakLaboratory of Bioinformatics and Protein Engineering, International Institute of Molecular and Cell Biology in Warsaw, ul. Ks. Trojdena 4, Warsaw, 02-109, Poland.ORCID 0000-0001-5758-9416

Funding

János Bolyai Research Scholarship of the Hungarian Academy of SciencesNational Research Development and Innovation Office of Hungary FK146063National Science Centre 2020/39/B/NZ2/03127
6 · The paper itself

Abstract

Nucleic acid molecules, including ribonucleic acid (RNA) and deoxyribonucleic acid (DNA), are essential for various biological processes and can adopt diverse 3D structures that serve as potential drug targets. The direct targeting of nucleic acid structures by small molecules represents an emerging field in drug design with enormous potential for providing therapeutic options for diseases that are currently not addressed, including genetic diseases and viral infections. In the early days of this promising field, a shortage of reliable structural data presents a bottleneck to the direct adaptation of structure-based methods, making the simpler yet powerful ligand-based approach an attractive alternative for virtual screening. In this study, we thoroughly evaluate and benchmark these methods against the reported binding of small molecules to diverse nucleic acid targets. We also compare these methods with structure-based molecular docking. Our results demonstrate that classification performance is significantly influenced by the applied descriptors, the chosen similarity measure, and the specific nucleic acid target. We have also proposed a consensus method that combines the best-performing algorithms of distinct nature. According to our studies, this approach outperforms all other tested methods, providing a valuable framework for nucleic acid-targeted drug discovery.

Indexed as

DNADrug DiscoveryNucleic AcidsRNASmall Molecule LibrariesAlgorithmsLigandsMolecular Docking SimulationNucleic Acid ConformationDNALigandsNucleic AcidsRNASmall Molecule LibrariesDNAmolecular fingerprintsnucleic acidsRNARNA-ligand interactionssimilarity

Identifiers

PMID41269280
PMCPMC12636511

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.